Indian Pharma Sector Exempt From Us Tariffs Indiabrains While most sectors face a 10% baseline tariff and india sees a 26% duty, the white house confirmed that pharmaceuticals, along with copper, semiconductors, and lumber, would be exempt. President donald trump on wednesday imposed an additional 25 percent duty on indian goods, raising overall tariffs to 50 percent. however, pharmaceutical exports—accounting for about 35 percent of india’s total pharma shipments to the u.s.—were excluded from the move.
Why Indian Pharma Sector Is Exempt From Trump S Tariffs The indian pharmaceutical sector has been excluded from immediate us tariff hikes due to the importance of generic medicines for affordable healthcare in the united states. this follows president trump's imposition of a 25% tariff on india over russian oil purchases, raising the total tariff to 50%. The united states has exempted indian pharmaceutical exports from its newly announced tariffs, ensuring indian drugmakers can continue supplying affordable medicines to the american. Us president donald trump has implemented an additional 25 per cent tariff on india, effective from wednesday, bringing the overall tariff to 50 per cent. however, india’s pharma exports to the us (accounting for 35 per cent of india’s total pharma exports) have been excluded from the tariffs. Us president donald trump has implemented an additional 25 per cent tariff on india, effective from wednesday, bringing the overall tariff to 50 per cent. however, india’s pharma exports to the us (accounting for 35 per cent of india’s total pharma exports) have been excluded from the tariffs.
Us Exempts Indian Pharma Sector From Reciprocal Tariffs The Eastern Times Us president donald trump has implemented an additional 25 per cent tariff on india, effective from wednesday, bringing the overall tariff to 50 per cent. however, india’s pharma exports to the us (accounting for 35 per cent of india’s total pharma exports) have been excluded from the tariffs. Us president donald trump has implemented an additional 25 per cent tariff on india, effective from wednesday, bringing the overall tariff to 50 per cent. however, india’s pharma exports to the us (accounting for 35 per cent of india’s total pharma exports) have been excluded from the tariffs. The good news is that pharmaceuticals, india's largest export to the us, are exempt from the 50% tariffs imposed by us president donald j. trump. the bad news is that trump has threatened global pharma specific tariffs that would come down hard on generic drug companies from india. Context: the united states government has announced a 100% tariff on branded and patented pharmaceutical products, effective october 1, 2025. the measure exempts companies that are building or expanding manufacturing plants in the u.s., signaling washington’s push for domestic production. President donald trump introduced sweeping new tariffs on 60 countries, including india, citing high import duties on american goods. while several indian export sectors, including automobiles, it, and jewellery, will face higher levies, pharmaceuticals and other essential items have been spared. The us has exempted indian pharmaceutical exports from new tariffs, ensuring continued access to affordable generic medicines, but uncertainty remains over future tariff changes.
Comments are closed.